Life Science Company News

Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »

Ellipses' next generation selective RET inhibitor EP0031/A400 cleared to start Phase 2

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

HER HIGHNESS SHEIKHA MOZA FORMALLY LAUNCHES QATAR PRECISION HEALTH INSTITUTE

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

STATEMENT - CMA recognizes National Physicians' Day

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Jacobio Pharma Announced its KRAS G12C inhibitor reached the primary endpoint

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Goldratt Consulting Supports a Breakthrough in Cancer Treatment Using Theory of Constraints (TOC)

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Clinical Trial Analytics Services Market Projected to Reach $11.95 billion by 2030 - Exclusive Report by 360iResearch

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Kidney Patients Issue National Health Alert on High Potassium

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

19th Annual BioFlorida Celebration of Biotechnology Highlights Booming Industry and Career Opportunities in Northeast Florida

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

MedStar Health Unveils $3.2 Million Expansion at Curtis National Hand Center VIP Event

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Korea Ginseng Corporation Held a Dedicated International Seminar at the International Conference on the Science of Botanicals (ICSB) About Korean Red Ginseng in the United States

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Waverley Pharma Business Update

Read more ››
By: PR Newswire Association LLC. - 01 May 2024

Better Choice is Encouraged by the Potential DEA Reclassification of Marijuana

Read more ››
By: GlobeNewswire - 30 Apr 2024

Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease

Read more ››
By: GlobeNewswire - 30 Apr 2024

Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Read more ››
By: GlobeNewswire - 30 Apr 2024

Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine

Read more ››
By: GlobeNewswire - 30 Apr 2024

Stryker reports first quarter 2024 operating results

Read more ››
By: GlobeNewswire - 30 Apr 2024

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024

Merit Medical Reports Results for First Quarter Ended March 31, 2024

Read more ››
By: GlobeNewswire - 30 Apr 2024
Results 281 - 300 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate